

Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure
Netflix stock dropped after the company posted disappointing subscriber growth and earnings for the latest quarter. Plus results from Snap and Texas Instruments. And Institutional Investor’s Top-Rated Biotech Analyst breaks down the outlook for companies racing to bring a coronavirus vaccine to market. And a moment of…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →
Countdown to NVIDIA Earnings, Anthropic IPO Watch, and More Tech Issues at Airlines

FAA Ground Stop, Anthropic IPO and What to Expect From Nvidia and Nike Next Week

FAA Ground Stop, Anthropic IPO and What to Expect From Nvidia and Nike Next Week
Similar episodes from other shows
More like CNBC's "Fast Money" →One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


